Person Career

2011 was a very exciting year for Accelerate Brain Cancer Cure in many ways, including our event and fundraising efforts.

At the end of 2010, we had our Race for Hope – DC and Florida Brain Cancer 5K events, but we knew that there was so much more we could be doing to help support the community and your desire to get involved in the fight against brain cancer.

We not only grew our existing events but also expanded our efforts to include some wonderful programs and partnerships:

Oldies but goodies…

Deck: 
Four Organizations Fund International Research Consortium to Improve Lives of Children Suffering From Diffuse Intrinsic Pontine Glioma (DIPG)

Accelerate Brain Cancer Cure (ABC2), CureSearch for Children’s Cancer, The Cure Starts Now Foundation and The Lyla Nsouli Foundation for Children’s Brain Cancer Research today announced their collaborative funding to support groundbreaking research aimed at dramatically improving the lives of children suffering from Diffuse Intrinsic Pontine Glioma (DIPG) – one of the most devastating pediatric cancers. 

Deck: 
Accelerate Brain Cancer Cure and Justin Friedlander are teaming up for the next inspirational journey in Justin's Quest to end brain cancer.

About Justin
NBA legend Michael Jordan once said, “Always turn a negative situation into a positive one.” Fourteen year-old athlete and sports fan Justin Friedlander is doing just that.

Justin is a normal 14 year-old boy. And as a healthy youngster, his dreams were not unlike those of others his age. Even now, Justin wrestles with his three brothers and plays with his dog. Break dancing and sports are his passion. While he may be the smallest player on the field, his competitive spirit and drive allow him to excel.

Deck: 
The international collaboration between Regulus Therapeutics and Samsung Medical Center aims to develop novel therapies for brain cancer.

The following is a press release from Regulus Therapeutics announcing the microRNA therapeutic effort in brain cancer.   

Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer

-Regulus, Accelerate Brain Cancer Cure (ABC2) and Samsung Medical Center to Advance microRNA Therapeutics for Glioblastoma -

The staff and board of Accelerate Brain Cancer Cure are deeply saddened by the passing of Bob Gibbs on December 10, 2011, more than 6 years after he was diagnosed with brain cancer.  Our sympathies go out to Bob's wife, Barb, and all the members of his family during this very difficult time. 

Deck: 
ABC2 helped fund early studies of the vaccine at Duke University.

The following is a press release from Celldex Therapeutics announcing positive survival data from their Rindopepimut Phase 2 Brain Cancer Vaccine Study and plans to initiate a Phase 3 trial.  Accelerate Brain Cancer Cure funded Duke University's early work on the vaccine. 

Celldex Therapeutics Reports Positive Mature Survival Data from Rindopepimut Phase 2 Brain Cancer Study at SNO 2011

-- Randomized International Phase 3 Trial to Initiate in 2011 --

Over 20,000 people lined up to participate in this year’s Marine Corps Marathon and 10K.  Among them were 40 runners proudly sporting bright orange running shirts.  These were the 40 runners who were part of Accelerate Brain Cancer Cure’s Race Towards A Cure team. 

Deck: 
Max Wallace, CEO of Accelerate Brain Cancer Cure, spoke to university and biotech industry groups about speeding the drug discovery and development process.

Max Wallace, CEO of Accelerate Brain Cancer Cure (ABC2), spent most of his career starting and building successful biotechnology companies.  His expertise in drug discovery, innovation and development make him a sought-after speaker at biomedical industry conferences across the country. 

ABC2 Science Salon: Brain Cancer Research at Scripps Florida

Tuesday, November 8, 2011

Derek Duckett, a top cancer researcher at the Florida campus of The Scripps Research Institute, will present a talk entitled, "Brain Cancer: Novel Therapies Fighting Back" on Tuesday, November 8th at The Club at Admiral's Cove in Jupiter, Florida.  Dr. Duckett is the associate scientific director of the Translational Research Institute at Scripps.  The event is hosted by The Rendina Family Foundation and co-sponsored by Genentech and Accelerate Brain Cancer Cure. 

Deck: 
$1 Million Research Grant Aims To Improve Treatments For Patients

Pages

Subscribe to RSS - Person Career
Share |

Join us in our fight for a cure!